Surgical Oncologist
Dilshod Maxmudovich Egamberdiyev
Hepatopancreatobiliary surgical oncology
Professional summary
Scientific head of the Hepatopancreatobiliary Surgery Department, Deputy Director for Strategic Planning and Public Health, with 20 years of practice. After training at the National Cancer Center of Korea in 2019, he initiated the founding of this specialised department at the centre. His practice rests on years of complex abdominal and HPB surgery and international standards.
Areas of expertise
- Pancreatic cancer and neuroendocrine tumour surgery, including the Whipple procedure
- Tumours of the bile ducts, ampulla of Vater, gallbladder and duodenum
- Liver surgery: primary tumours and metastases
- Complex abdominal and retroperitoneal oncological surgery
Education & training
Clinical residency in oncology, Republican Oncology Centre (2003–2005); postgraduate study and PhD (2006–2009)
International programmes: NCI, Thomas Jefferson University Hospital and UPMC (USA); National Cancer Center Korea (HPB surgery and liver transplantation); Johns Hopkins Singapore; Ege University Hospital (Türkiye)
Certifications & licenses
MD (2003); PhD in oncology and surgery (2012); certified in hepatopancreatobiliary surgical oncology (2019); physician-oncologist of the highest category.
Achievements & research
Initiated the centre's first specialised hepatopancreatobiliary surgery department (2019) and the adoption of international treatment standards. Author of more than 100 scientific works on the surgical treatment of gastric, pancreatic and liver cancer.